ATE126066T1 - Anwendung von chelaten von konjugaten mit paramagnetischen metallen für targetting. - Google Patents

Anwendung von chelaten von konjugaten mit paramagnetischen metallen für targetting.

Info

Publication number
ATE126066T1
ATE126066T1 AT91810589T AT91810589T ATE126066T1 AT E126066 T1 ATE126066 T1 AT E126066T1 AT 91810589 T AT91810589 T AT 91810589T AT 91810589 T AT91810589 T AT 91810589T AT E126066 T1 ATE126066 T1 AT E126066T1
Authority
AT
Austria
Prior art keywords
targetting
chelates
conjugates
application
bond
Prior art date
Application number
AT91810589T
Other languages
English (en)
Inventor
Paul Palacios
Original Assignee
Bracco Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Int Bv filed Critical Bracco Int Bv
Application granted granted Critical
Publication of ATE126066T1 publication Critical patent/ATE126066T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • A61K49/146Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • A61K49/16Antibodies; Immunoglobulins; Fragments thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Measurement Of Force In General (AREA)
  • Aerodynamic Tests, Hydrodynamic Tests, Wind Tunnels, And Water Tanks (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT91810589T 1991-07-22 1991-07-22 Anwendung von chelaten von konjugaten mit paramagnetischen metallen für targetting. ATE126066T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810589A EP0529175B1 (de) 1991-07-22 1991-07-22 Anwendung von Chelaten von Konjugaten mit paramagnetischen Metallen für Targetting

Publications (1)

Publication Number Publication Date
ATE126066T1 true ATE126066T1 (de) 1995-08-15

Family

ID=8208865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91810589T ATE126066T1 (de) 1991-07-22 1991-07-22 Anwendung von chelaten von konjugaten mit paramagnetischen metallen für targetting.

Country Status (16)

Country Link
US (2) US5414114A (de)
EP (1) EP0529175B1 (de)
JP (1) JP3463810B2 (de)
KR (1) KR100191563B1 (de)
AT (1) ATE126066T1 (de)
AU (1) AU664192B2 (de)
CA (1) CA2090033C (de)
DE (2) DE69112053D1 (de)
DK (1) DK0529175T3 (de)
ES (1) ES2075402T3 (de)
FI (1) FI931070A0 (de)
GR (1) GR3017326T3 (de)
HU (1) HUT63344A (de)
IE (1) IE68854B1 (de)
NO (1) NO305464B1 (de)
WO (1) WO1993001837A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284208A (en) 1993-11-25 1995-05-31 Pna Diagnostics As Nucleic acid analogues with a chelating functionality for metal ions
US6232295B1 (en) 1994-10-12 2001-05-15 Jon Faiz Kayyem Cell-specific contrast agent and gene delivery vehicles
US6962686B2 (en) 1994-10-12 2005-11-08 California Institute Of Technology Cell-specific gene delivery vehicles
US7317070B1 (en) * 2004-03-12 2008-01-08 Sigma-Aldrich Co. Process for the preparation of polyamino acids
US7205385B2 (en) * 2004-11-12 2007-04-17 General Electric Company Polymerization method for the synthesis of polypeptide imaging agents
EP2031010B1 (de) * 2006-06-08 2014-04-23 The University of Tokushima Verfahren zur herstellung von neuem siliciumdioxid-nanoteilchen und verwendung des siliciumdioxid-nanoteilchens
PL2307448T3 (pl) * 2008-08-07 2015-10-30 Sigma Aldrich Co Llc Wytwarzanie polilizyny i poliornityny o małym ciężarze cząsteczkowym z wysoką wydajnością
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040506B1 (de) * 1980-05-21 1986-08-20 Teijin Limited Reaktives Polymer und Verfahren zu seiner Herstellung
FR2586813B1 (fr) * 1985-08-30 1989-05-12 Inst Nat Sante Rech Med Supports proteiques modifies aptes a immobiliser de facon reversible des anticorps ou des substances immunologiquement actives, et leurs applications au dosage et a la purification d'antigenes ou similaires.
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
JPH01126555A (ja) * 1987-11-11 1989-05-18 Meidensha Corp 免疫測定用試薬

Also Published As

Publication number Publication date
KR100191563B1 (ko) 1999-06-15
WO1993001837A1 (en) 1993-02-04
NO930894D0 (no) 1993-03-11
JPH06502192A (ja) 1994-03-10
EP0529175B1 (de) 1995-08-09
DE69112053D1 (de) 1995-09-14
IE68854B1 (en) 1996-07-24
FI931070A (fi) 1993-03-10
JP3463810B2 (ja) 2003-11-05
US5571940A (en) 1996-11-05
EP0529175A1 (de) 1993-03-03
AU664192B2 (en) 1995-11-09
CA2090033A1 (en) 1993-01-23
DE69112053T4 (de) 1996-08-22
NO930894L (no) 1993-03-11
DK0529175T3 (da) 1995-11-06
CA2090033C (en) 2000-05-16
HU9300802D0 (en) 1993-06-28
US5414114A (en) 1995-05-09
DE69112053T2 (de) 1996-05-02
ES2075402T3 (es) 1995-10-01
KR930701174A (ko) 1993-06-11
HUT63344A (en) 1993-08-30
IE922362A1 (en) 1993-01-27
GR3017326T3 (en) 1995-12-31
NO305464B1 (no) 1999-06-07
FI931070A0 (fi) 1993-03-10
AU2274192A (en) 1993-02-23

Similar Documents

Publication Publication Date Title
ATE320001T1 (de) Durch fluoreszierenden polymer markierte konjugate und zwischen produkte
CA2150925A1 (en) Improved synthesis of polymer bio-active conjugates
ATE126066T1 (de) Anwendung von chelaten von konjugaten mit paramagnetischen metallen für targetting.
ATE496633T1 (de) Reinigung von polysaccharid-protein-konjugat impfstoffen durch ultrafiltration mit ammoniumsulfat-lösungen
DK250886A (da) Fremgangsmaade til taet afbinding af et indsnaevringssted paa en roerfolieemballage bestaaende af formstoffolie med hoej taethed, samt binder til brug herved
ATE243319T1 (de) Bor-neutronen-einfangtherapie unter verwendung von pre-targeting-methoden
DE69726709D1 (de) Verbindungen und verfahren zur herstellung von sulphoindocyaninfarbstoffen
CA2172663A1 (en) Improved reagents for a cannabinoid immunoassay
DK0760870T3 (da) Jernphosphatering under anvendelse af substituerede monocarboxylsyrer
FR2640006B1 (fr) Procede d'assemblage, par collage, de deux pieces ou substrats
DK0946525T3 (da) Fremgangsmåde til fremstilling af metalkomplekscarboxylsyreamider
Koshiba et al. L-and D-tryptophan aminotransferases from maize coleoptiles
EP0882767A4 (de) Disazoverbindungen und ihre herstellungsverfahren
FR2422699A1 (fr) Procede de preparation d'un materiau solide poreux revetu de cellulose ou de cellulose modifiee
EP0601318A3 (de) Verfahren zur Herstellung von Konjugaten aus einem spezifischen Bindungspartner und einem kohlenhydrathaltigen Protein.
ATE198900T1 (de) Polymerisierbare und/oder vernetzbare durch oder uv- oder sichtbare lichtbeschichtungsmisschungen
SE9201731L (sv) Härdare innehållande alkylaminsalter förlimning med aminobaserade lim av träbaserade podukter
NO970546D0 (no) ICAM-4-materialer og metoder
WO1993020852A3 (en) Macrocyclic chelating agents, chelates and conjugates thereof
KR970700698A (ko) 폴리아미노카르복실레이트 킬레이트제(new polyaminocarboxylate chelators)
CA2117599A1 (en) Method for modulating proopiomelanocortin synthesis in a mammal
DK0828848T3 (da) Fremstilling af hydroxyforbindelser ved bioomdannelse med dioxygenase
HUP0002977A2 (hu) Target sejtek irányított citolízise, citolízist okozó szerek és kompozíciók, valamint ilyen szerek előállítására alkalmazható vegyületek

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee